TY - JOUR
T1 - A new look at cognitive functioning in pediatric MS
AU - the US Network of Pediatric MS Centers
AU - Krupp, Lauren B.
AU - Waubant, Emmanuelle
AU - Waltz, Michael
AU - Casper, T. Charles
AU - Belman, Anita
AU - Wheeler, Yolanda
AU - Ness, Jayne
AU - Graves, Jennifer
AU - Gorman, Mark
AU - Benson, Leslie
AU - Mar, Soe
AU - Goyal, Manu
AU - Schreiner, Teri
AU - Weinstock-Guttman, Bianca
AU - Rodriguez, Moses
AU - Tillema, Jan Mendelt
AU - Lotze, Timothy
AU - Aaen, Greg
AU - Rensel, Mary
AU - Rose, John
AU - Chitinis, Tanuja
AU - George, Allan
AU - Charvet, Leigh E.
N1 - Publisher Copyright:
© The Author(s), 2022.
PY - 2023/1
Y1 - 2023/1
N2 - Objective: Cognitive involvement in pediatric multiple sclerosis (MS) relative to adult MS is less defined. This study advances our understanding by measuring cognitive performances in pediatric MS, adult MS, and pediatric healthy controls. Methods: Consecutive relapsing pediatric MS participants from the United States Network of Pediatric MS Centers were compared with pediatric healthy controls and adults with relapsing MS. Participants were compared on two screening batteries: the Brief International Cognitive Assessment for MS and the Cogstate Brief Battery. Results were transformed to age-normative z scores. Results: The pediatric groups (MS vs. Healthy Controls) did not differ on either battery’s composite mean score or individual test scores (ps > 0.32), nor in the proportions impaired on either battery, Brief International Cognitive Assessment for MS (26% vs. 24%, p = 0.83); Cogstate Brief Battery (26% vs. 32%, p = 0.41). The pediatric versus adult MS group even after controlling for differences in disease duration performed better on the Brief International Cognition Assessment for MS composite (p = 0.03), Symbol Digit Modalities Test (p = 0.02), Rey Auditory Verbal Learning Test (p = 0.01), and Cogstate choice reaction time (p < 0.001). Conclusion: Pediatric MS patients do not differ from healthy pediatric controls on cognitive screens but perform better than adults with MS.
AB - Objective: Cognitive involvement in pediatric multiple sclerosis (MS) relative to adult MS is less defined. This study advances our understanding by measuring cognitive performances in pediatric MS, adult MS, and pediatric healthy controls. Methods: Consecutive relapsing pediatric MS participants from the United States Network of Pediatric MS Centers were compared with pediatric healthy controls and adults with relapsing MS. Participants were compared on two screening batteries: the Brief International Cognitive Assessment for MS and the Cogstate Brief Battery. Results were transformed to age-normative z scores. Results: The pediatric groups (MS vs. Healthy Controls) did not differ on either battery’s composite mean score or individual test scores (ps > 0.32), nor in the proportions impaired on either battery, Brief International Cognitive Assessment for MS (26% vs. 24%, p = 0.83); Cogstate Brief Battery (26% vs. 32%, p = 0.41). The pediatric versus adult MS group even after controlling for differences in disease duration performed better on the Brief International Cognition Assessment for MS composite (p = 0.03), Symbol Digit Modalities Test (p = 0.02), Rey Auditory Verbal Learning Test (p = 0.01), and Cogstate choice reaction time (p < 0.001). Conclusion: Pediatric MS patients do not differ from healthy pediatric controls on cognitive screens but perform better than adults with MS.
KW - BICAMS
KW - Cogstate
KW - Pediatric MS
KW - adult MS
KW - cognition
KW - cognitive screening
UR - http://www.scopus.com/inward/record.url?scp=85139212639&partnerID=8YFLogxK
U2 - 10.1177/13524585221123978
DO - 10.1177/13524585221123978
M3 - Article
C2 - 36189711
AN - SCOPUS:85139212639
SN - 1352-4585
VL - 29
SP - 140
EP - 149
JO - Multiple Sclerosis Journal
JF - Multiple Sclerosis Journal
IS - 1
ER -